ELI LILLY & COMPANY INDIA PVT LTD

Gurugram headquartered Eli Lilly and Company (India), a wholly owned subsidiary of US-based biopharmaceutical firm Eli Lilly and Company recorded a revenue of Rs 172 crore in the biopharma space during FY 20-21, showing a slight decline when compared to Rs 183 crore generated during FY 19-20. Since its inception in India in 1993, the company has been committed to developing and marketing pharmaceutical products to treat diabetes, gastric cancer, lung cancer, osteoporosis, rheumatoid arthritis, men’s health and growth-hormone deficiency. Lilly India affiliate comprises operations in Nepal, Bangladesh and Sri Lanka.